Aflac Incorporated (NYSE:AFL) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans decreased its holdings in Aflac Incorporated (NYSE:AFL) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 27,208 shares of the financial services provider’s stock after selling 218 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Aflac were worth $2,834,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Franklin Resources Inc. grew its holdings in shares of Aflac by 75.2% in the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after acquiring an additional 333,083 shares during the last quarter. Roxbury Financial LLC acquired a new position in shares of Aflac in the 4th quarter valued at $948,000. FMR LLC increased its stake in Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after purchasing an additional 45,745 shares in the last quarter. Willis Investment Counsel raised its holdings in Aflac by 1.2% during the 4th quarter. Willis Investment Counsel now owns 273,466 shares of the financial services provider’s stock worth $28,287,000 after buying an additional 3,357 shares during the period. Finally, Board of the Pension Protection Fund purchased a new stake in Aflac during the fourth quarter valued at about $1,014,000. Institutional investors own 67.44% of the company’s stock.

Aflac Trading Up 0.4 %

NYSE:AFL opened at $110.87 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a market capitalization of $60.60 billion, a P/E ratio of 11.55, a P/E/G ratio of 3.24 and a beta of 0.93. The stock’s 50 day moving average price is $106.42 and its 200 day moving average price is $107.66. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AFL has been the topic of several analyst reports. Keefe, Bruyette & Woods dropped their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. JPMorgan Chase & Co. increased their target price on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. BMO Capital Markets began coverage on Aflac in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price for the company. Finally, Barclays dropped their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Aflac has a consensus rating of “Hold” and an average price target of $103.36.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.